Hemodynamic Monitoring in Patients With Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
Journal
Journal of neurosurgical anesthesiology
ISSN: 1537-1921
Titre abrégé: J Neurosurg Anesthesiol
Pays: United States
ID NLM: 8910749
Informations de publication
Date de publication:
01 Oct 2021
01 Oct 2021
Historique:
received:
09
08
2019
accepted:
29
12
2019
pubmed:
6
2
2020
medline:
15
12
2021
entrez:
4
2
2020
Statut:
ppublish
Résumé
Aneurysmal subarachnoid hemorrhage (aSAH) often causes cardiopulmonary dysfunction. Therapeutic strategies can be guided by standard (invasive arterial/central venous pressure measurements, fluid balance assessment), and/or advanced (pulse index continuous cardiac output, pulse dye densitometry, pulmonary artery catheterization) hemodynamic monitoring. We conducted a systematic review and meta-analysis of the literature to determine whether standard compared with advanced hemodynamic monitoring can improve patient management and clinical outcomes after aSAH. A literature search was performed for articles published between January 1, 2000 and January 1, 2019. Studies involving aSAH patients admitted to the intensive care unit and subjected to any type of hemodynamic monitoring were included. A total of 14 studies were selected for the qualitative synthesis and 3 randomized controlled trials, comparing standard versus advanced hemodynamic monitoring, for meta-analysis. The incidence of delayed cerebral ischemia was lower in the advanced compared with standard hemodynamic monitoring group (relative risk [RR]=0.71, 95% confidence interval [CI]=0.52-0.99; P=0.044), but there were no differences in neurological outcome (RR=0.83, 95% CI=0.64-1.06; P=0.14), pulmonary edema onset (RR=0.44, 95% CI=0.05-3.92; P=0.46), or fluid intake (mean difference=-169 mL; 95% CI=-1463 to 1126 mL; P=0.8) between the 2 groups. In summary, this systematic review and meta-analysis found only low-quality evidence to support the use of advanced hemodynamic monitoring in selected aSAH patients. Because of the small number and low quality of studies available for inclusion in the review, further studies are required to investigate the impact of standard and advanced hemodynamic monitoring-guided management on aSAH outcomes.
Identifiants
pubmed: 32011413
pii: 00008506-202110000-00002
doi: 10.1097/ANA.0000000000000679
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-292Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
D’Souza S. Aneurysmal subarachnoid haemorrhage. J Neurosurg Anesthesiol. 2015;27:222–240.
Etminan N, Chang H-S, Hackenberg K, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population. JAMA Neurol. 2019;76:588–597.
Macdonald RL, Diringer MN, Citerio G. Understanding the disease: aneurysmal subarachnoid hemorrhage. Intensive Care Med. 2014;40:1940–1943.
Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid haemorrhage. Crit Care Med. 2006;34:617–623.
Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med. 2002;28:1012–1023.
Solenski NJ, Haley ECJ, Kassell NF, et al. Medical complications of aneurysmal subarachnoid haemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23:1007–1017.
Hall A, O’Kane R. The extracranial consequences of subarachnoid haemorrhage. World Neurosurg. 2018;109:381–392.
Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid haemorrhage. J Neurosurg Anesthesiol. 2008;20:188–192.
Sommargren CE, Zaroff JG, Banki N, et al. Electrocardiographic repolarization abnormalities in subarachnoid haemorrhage. J Electrocardiol. 2002;35(suppl):257–262.
Salvati M, Cosentino F, Artico M, et al. Electrocardiographic changes in subarachnoid haemorrhage secondary to cerebral aneurysm. Report of 70 cases. Ital J Neurol Sci. 1992;13:409–413.
Zaroff JG, Rordorf GA, Ogilvy CS, et al. Regional patterns of left ventricular systolic dysfunction after subarachnoid haemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000;13:774–779.
Inamasu J, Sugimoto K, Yamada Y, et al. The role of catecholamines in the pathogenesis of neurogenic pulmonary edema associated with subarachnoid haemorrhage. Acta Neurochir (Wien). 2012;154:2179–2185.
Tagami T, Kuwamoto K, Watanabe A, et al. SAH PiCCO Study Group. Optimal range of global end-diastolic volume for fluid management after aneurysmal subarachnoid haemorrhage: a multicenter prospective cohort study. Crit Care Med. 2014;42:1348–1356.
Hoff R, Rinkel G, Verweij B, et al. Blood volume measurement to guide fluid therapy after aneurysmal subarachnoid haemorrhage. A prospective controlled study. Stroke. 2009;40:2575–2577.
Mutoh T, Kazumata K, Terasaka S, et al. Early intensive versus minimally invasive approach to postoperative haemodynamic management after subarachnoid haemorrhage. Stroke. 2014;45:1280–1284.
Mutoh T, Kazumata K, Ishikawa T, et al. Performance of bedside transpulmonary thermodilution monitoring for goal-directed haemodynamic management after subarachnoid haemorrhage. Stroke. 2009;40:2368–2374.
Vergouw LJM, Egal M, Bergmans B, et al. High early fluid input after aneurysmal subarachnoid haemorrhage: combined report of association with delayed cerebral ischemia and feasibility of cardiac output–guided fluid restriction. J Intensive Care Med. 2020;35:161–169.
Mutoh T, Kazumata K, Terasaka S, et al. Impact of transpulmonary thermodilution-based cardiac contractility and extravascular lung water measurements on clinical outcome of patients with Takotsubo cardiomyopathy after subarachnoid haemorrhage: a retrospective observational study. Crit Care. 2014;18:482.
Yoneda H, Nakamura T, Shirao S, et al. SAH PiCCO Study Group. Multicenter prospective cohort study on volume management after subarachnoid haemorrhage haemodynamic changes according to severity of subarachnoid haemorrhage and cerebral vasospasm. Stroke. 2013;44:2155–2161.
Hoff RG, van Dijk GW, Algra A, et al. Fluid balance and blood volume measurement after aneurysmal subarachnoid haemorrhage. Neurocrit Care. 2008;8:391–397.
Mutoh T, Ishikawa T, Kobayashi S, et al. Performance of third-generation FloTrac/Vigileo system during hyperdynamic therapy for delayed cerebral ischemia after subarachnoid haemorrhage. Surg Neurol Int. 2012;3:99.
Obata Y, Takeda J, Sato Y, et al. A multicenter prospective cohort study of volume management after subarachnoid haemorrhage: circulatory characteristics of pulmonary edema after subarachnoid haemorrhage. J Neurosurg. 2016;125:254–263.
Taccone FS, Citerio G. Participants in the International Multi-disciplinary Consensus Conference on Multimodality Monitoring. Advanced monitoring of systemic hemodynamics in critically ill patients with acute brain injury. Neurocrit Care. 2014;21(suppl 2):S38–S63.
Diringer MN, Bleck TP, Hemphill JC III, et al. Critical care management of patients following aneurysmal subarachnoid haemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–240.
Mutoh T, Kazumata K, Ajiki M, et al. Goal-directed fluid management by bedside transpulmonary haemodynamic monitoring after subarachnoid haemorrhage. Stroke. 2007;38:3218–3224.
Whitener S, Konoske R, Mark JB. Pulmonary artery catheter. Best Pract Res Clin Anaesthesiol. 2014;28:323–335.
Youssef N, Whitlock RP. The routine use of the pulmonary artery catheter should be abandoned. Can J Cardiol. 2017;33:135–141.
Chatterjee K. The Swan-Ganz catheters: past, present, and future. A viewpoint. Circulation. 2009;119:147–152.
Moher D, Shamseer L, Clarke M, et al. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
Kavanagh BP. The GRADE System for Rating Clinical Guidelines. PLoS Med. 2009;6:e1000094.
The Nordic Cochrane Centre. Review Manager (RevMan) [Computer program], Version 53. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
Hoff RG, Rinkel GJ, Verweij BH, et al. Pulmonary edema and blood volume after aneurysmal subarachnoid haemorrhage: a prospective observational study. Crit Care. 2010;14:R43.
Metzelder SM, Coburn M, Stoppe C, et al. Accuracy and precision of calibrated arterial pulse contour analysis in patients with subarachnoid haemorrhage requiring high-dose vasopressor therapy: a prospective observational clinical trial. Crit Care. 2014;18:R25.
Kasuya H, Onda H, Yoneyama T, et al. Bedside monitoring of circulating blood volume after subarachnoid haemorrhage. Stroke. 2003;34:956–960.
Van Loon J, Shivalkar B, Plets C, et al. Catecholamine response to a gradual increase of intracranial pressure. J Neurosurg. 1993;79:705–709.
De Oliveira Manoel AL, Goffi A, Marotta TR, et al. The critical care management of poorgrade subarachnoid haemorrhage. Crit Care. 2016;20:21.
Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2013;10:44–58.
Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid haemorrhage: a randomized controlled trial. Stroke. 2000;31:383–391.
Dankbaar JW, Slooter AJ, Rinkel GJ, et al. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14:R23.
Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid haemorrhage. Crit Care Med. 2007;35:1844–1851.
Raabe A, Beck J, Keller M, et al. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid haemorrhage. J Neurosurg. 2005;103:974–981.
Ekelund A, Reinstrup P, Ryding E, et al. Effects of iso- and hypervolemic haemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2002;144:703–712.
Wolf S. The participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Haemorrhage. Routine management of volume status after aneurysmal subarachnoid haemorrhage. Neurocrit Care. 2011;15:275–280.
Veeravagu A, Chen YR, Ludwig C, et al. Acute lung injury in patients with subarachnoid haemorrhage: a Nationwide Inpatient Sample Study. World Neurosurg. 2014;82:e235–e241.
Egge A, Waterloo K, Sjøholm H, et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid haemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery. 2001;49:593–605.
Huygh J, Peeters Y, Bernards J, et al. Haemodynamic monitoring in the critically ill: an overview of current cardiac output monitoring methods. F1000Res. 2016;5:2855.
Murad MH, Montori VM, Ioannidis JP, et al. How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA. 2014;312:171–179.